{"entity":{"type":"insider","cik":"0001316736","url":"/insider/0001316736","json_url":"/insider/0001316736.json","name":"Pedder Simon","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":9,"first":"2006-08-24","last":"2019-08-29","span_basis":"filed_date"},"name_variants":[{"name":"Pedder Simon","source":"filing","n_filings":9,"first_seen":"2006-08-24","last_seen":"2019-08-29"}],"transactions":[{"id":7923647,"accession":"0001578563-19-000025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001578563-19-000025","line_url":"/filing/0001578563-19-000025#line-1","is_derivative":false,"issuer_cik":"0001316736","issuer_name":"Cerecor Inc.","issuer_ticker":"CERC","issuer_name_source":null,"issuer_url":"/issuer/0001316736","owner_cik":"0001316736","owner_name":"Pedder Simon","owner_display_name":"Pedder Simon","owner_url":"/insider/0001316736","role":"Director, Officer (Executive Chairman of the Bd)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman of the Bd","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6734.0,"shares_display":"6,734","price_per_share":2.9849,"price_display":"2.98","price_state":"stated","total_value":20100.3166,"total_display":"20,100.32","total_whole":"20,100","shares_owned_after":262734.0,"shares_owned_after_display":"262,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-27","filed_date":"2019-08-29","scope":"insider"},{"id":8430753,"accession":"0001578563-19-000016","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001578563-19-000016","line_url":"/filing/0001578563-19-000016#line-1","is_derivative":false,"issuer_cik":"0001316736","issuer_name":"Cerecor Inc.","issuer_ticker":"CERC","issuer_name_source":null,"issuer_url":"/issuer/0001316736","owner_cik":"0001316736","owner_name":"Pedder Simon","owner_display_name":"Pedder Simon","owner_url":"/insider/0001316736","role":"Director, Officer (Executive Chairman of the Bd)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman of the Bd","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":5.056,"price_display":"5.06","price_state":"stated","total_value":30336.0,"total_display":"30,336.00","total_whole":"30,336","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-14","filed_date":"2019-05-16","scope":"insider"},{"id":6080021,"accession":"0001209191-18-058608","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-058608","line_url":"/filing/0001209191-18-058608#line-1","is_derivative":false,"issuer_cik":"0001300699","issuer_name":"Athenex, Inc.","issuer_ticker":"ATNX","issuer_name_source":null,"issuer_url":"/issuer/0001300699","owner_cik":"0001316736","owner_name":"Pedder Simon","owner_display_name":"Pedder Simon","owner_url":"/insider/0001316736","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2908.0,"shares_display":"2,908","price_per_share":10.258,"price_display":"10.26","price_state":"stated","total_value":29830.264,"total_display":"29,830.26","total_whole":"29,830","shares_owned_after":3908.0,"shares_owned_after_display":"3,908","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-14","filed_date":"2018-11-14","scope":"insider"},{"id":9206334,"accession":"0000905148-17-000703","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-17-000703","line_url":"/filing/0000905148-17-000703#line-1","is_derivative":false,"issuer_cik":"0001300699","issuer_name":"Athenex, Inc.","issuer_ticker":"ATNX","issuer_name_source":null,"issuer_url":"/issuer/0001300699","owner_cik":"0001316736","owner_name":"Pedder Simon","owner_display_name":"Pedder Simon","owner_url":"/insider/0001316736","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":11000.0,"total_display":"11,000.00","total_whole":"11,000","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-19","filed_date":"2017-07-28","scope":"insider"},{"id":6902394,"accession":"0001144204-14-052132","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-14-052132","line_url":"/filing/0001144204-14-052132#line-1","is_derivative":false,"issuer_cik":"0001279704","issuer_name":"Cellectar Biosciences, Inc.","issuer_ticker":"CLRB","issuer_name_source":null,"issuer_url":"/issuer/0001279704","owner_cik":"0001316736","owner_name":"Pedder Simon","owner_display_name":"Pedder Simon","owner_url":"/insider/0001316736","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock, par value $0.00001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13300.0,"shares_display":"13,300","price_per_share":3.75,"price_display":"3.75","price_state":"stated","total_value":49875.0,"total_display":"49,875.00","total_whole":"49,875","shares_owned_after":13300.0,"shares_owned_after_display":"13,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-20","filed_date":"2014-08-22","scope":"insider"},{"id":7507836,"accession":"0001181431-10-045686","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-10-045686","line_url":"/filing/0001181431-10-045686#line-1","is_derivative":false,"issuer_cik":"0001316736","issuer_name":"Chelsea Therapeutics International, Ltd.","issuer_ticker":"CHTP","issuer_name_source":null,"issuer_url":"/issuer/0001316736","owner_cik":"0001316736","owner_name":"Pedder Simon","owner_display_name":"Pedder Simon","owner_url":"/insider/0001316736","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1250.0,"shares_display":"1,250","price_per_share":4.08,"price_display":"4.08","price_state":"stated","total_value":5100.0,"total_display":"5,100.00","total_whole":"5,100","shares_owned_after":488180.0,"shares_owned_after_display":"488,180","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-09-02","filed_date":"2010-09-07","scope":"insider"},{"id":6032298,"accession":"0001181431-09-057906","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-09-057906","line_url":"/filing/0001181431-09-057906#line-1","is_derivative":false,"issuer_cik":"0001316736","issuer_name":"Chelsea Therapeutics International, Ltd.","issuer_ticker":"CHTP","issuer_name_source":null,"issuer_url":"/issuer/0001316736","owner_cik":"0001316736","owner_name":"Pedder Simon","owner_display_name":"Pedder Simon","owner_url":"/insider/0001316736","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4600.0,"shares_display":"4,600","price_per_share":2.2,"price_display":"2.20","price_state":"stated","total_value":10120.0,"total_display":"10,120.00","total_whole":"10,120","shares_owned_after":486930.0,"shares_owned_after_display":"486,930","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-17","filed_date":"2009-12-21","scope":"insider"},{"id":3647682,"accession":"0001181431-08-054351","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-08-054351","line_url":"/filing/0001181431-08-054351","is_derivative":false,"issuer_cik":"0001316736","issuer_name":"Chelsea Therapeutics International, Ltd.","issuer_ticker":"CHTP","issuer_name_source":null,"issuer_url":"/issuer/0001316736","owner_cik":"0001316736","owner_name":"Pedder Simon","owner_display_name":"Pedder Simon","owner_url":"/insider/0001316736","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":2.905666666666667,"price_display":"2.91","price_state":"stated","total_value":8717.0,"total_display":"8,717.00","total_whole":"8,717","shares_owned_after":482330.0,"shares_owned_after_display":"482,330","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-09-24","filed_date":"2008-09-24","scope":"insider","n_lines":3},{"id":3367924,"accession":"0001181431-06-049464","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-06-049464","line_url":"/filing/0001181431-06-049464#line-1","is_derivative":false,"issuer_cik":"0001316736","issuer_name":"Chelsea Therapeutics International, Ltd.","issuer_ticker":"CHTP.OB","issuer_name_source":null,"issuer_url":"/issuer/0001316736","owner_cik":"0001316736","owner_name":"Pedder Simon","owner_display_name":"Pedder Simon","owner_url":"/insider/0001316736","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":3.267,"price_display":"3.27","price_state":"stated","total_value":3267.0,"total_display":"3,267.00","total_whole":"3,267","shares_owned_after":479330.0,"shares_owned_after_display":"479,330","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-08-23","filed_date":"2006-08-24","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":11,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001534120","name":"Cerecor Inc.","url":"/issuer/0001534120","role":"Director, Officer (Executive Chairman of the Bd)","n_filings":2,"first_seen":"2019-05-16","last_seen":"2019-08-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001300699","name":"Athenex, Inc.","url":"/issuer/0001300699","role":"Officer","n_filings":2,"first_seen":"2017-07-28","last_seen":"2018-11-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001279704","name":"Cellectar Biosciences, Inc.","url":"/issuer/0001279704","role":"Director, Officer (President and CEO)","n_filings":1,"first_seen":"2014-08-22","last_seen":"2014-08-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001333763","name":"Chelsea Therapeutics International, Ltd.","url":"/issuer/0001333763","role":"Director, Officer (Chief Executive Officer)","n_filings":4,"first_seen":"2006-08-24","last_seen":"2010-09-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001316736","retrieved_at":"2026-08-22T23:06:28+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}